Một dự án của Lê Mai A Lê Mai project · go to lemai.com.vn

β-Myrcene

7-Methyl-3-methylene-1,6-octadiene

Myrcene

Aliphatic monoterpenoid alkene · C₁₀H₁₆

Chemical structure of β-Myrcene
2D structure PubChem / NCI CIR

Chemical info

CAS number CAS
123-35-3
Molecular formula
C₁₀H₁₆
Molecular weight
136.23 g/mol
Aroma
Balsamic, green herbal, lightly resinous and fruity. A common base note across many essential oils.

Safety

Low concern · Safe at standard use

β-Myrcene is an aliphatic monoterpene abundant in many essential oils, particularly the β-myrcene chemotype of rosemary, hop and West Indian bay. The compound is considered non-irritant, non-allergenic and non-toxic at standard use levels.

Skin. Undiluted β-myrcene was moderately irritating to rabbit skin. A 4 percent test on 25 volunteers caused no irritation and no sensitization. In a study of 1,511 dermatitis patients, only 0.07 percent reacted to 3 percent oxidized β-myrcene.

Acute toxicity. Acute oral LD50 in rats exceeded 5 g/kg. The rat oral NOAEL is 300 mg/kg. In a 14-week high-dose study (250 to 4,000 mg/kg/day), 39 of 40 high-dose rats died within the first week. The 250 mg/kg low dose was safe for hematology.

Reproductive. Oral doses up to 2 g/kg in rats and 1 g/kg in mice had no effect on reproductive organ weight, sperm count or estrus cycle. Rat reproductive NOAEL was 250 mg/kg.

Mutagenicity. Non-mutagenic in Ames tests. Shows strong antimutagenic activity through concentration-dependent PROD inhibition. May reduce genotoxicity of DMBA, benzo[a]pyrene and cyclophosphamide.

Cancer. Renal tubule lesions in male rats, the male rat-specific pattern also seen with (+)-limonene and 1,8-cineole, not relevant to humans. Some liver tumors in male mice at high doses, not mirrored in rats. The massive doses and modest purity of β-myrcene used in the study make data difficult to extrapolate to humans.


Usage guidelines

Concern level
Low
Rat oral NOAEL
300 mg/kg
Rat reproductive NOAEL
250 mg/kg
Regulatory limit
No IFRA or EU limit set specifically

Found in essential oils

Principal sources
Cape May43.8 %
Celery leaf33.6 %
Hop25.4 %
Bay (West Indian)6.4 – 25.0 %
Parsley leaf7.8 – 23.8 %
Juniperberry0 – 22.0 %
Pepper (pink)5.0 – 20.4 %
African bluegrass15.4 – 20.2 %
Lemongrass5.6 – 19.2 %
Pepper (Sichuan)16.4 %
Lavender cotton3.6 – 15.0 %
Tansy (blue)1.1 – 13.8 %
Pine (white)4.7 – 13.1 %
Mastic0.2 – 12.3 %
Myrtle (honey)10.9 %
Pteronia10.3 %
Myrtle (bog)9.5 %
Goldenrod9.4 %
Grindelia14.0 – 26.0 %
Verbena (honey)4.7 – 8.3 %
Ravensara leaf5.0 – 7.3 %
Yarrow (chamazulene CT)7.0 %
Pine (dwarf)0.5 – 7.0 %
Pine (grey)4.1 – 6.1 %
Angelica root1.6 – 5.5 %
Spruce (Norway)3.0 – 5.2 %
Pine (red)4.3 – 5.0 %

Pharmacokinetics

β-Myrcene given intragastrically for 20 consecutive days is mainly metabolized to a pair of glycols, via epoxidation and hydration, followed by oxidation to a corresponding pair of hydroxycarboxylic acids. In rats given 1 g/kg, blood levels at 60 minutes were 14.1 µg/mL with a half-life of 285 minutes.

β-Myrcene is an inducer of isoenzymes belonging to the CYP2B subfamily. The compound prolongs pentobarbital-induced sleeping time in rats, probably by inhibiting the barbiturate's metabolism by CYP.


Notes

Only the β-isomer of myrcene occurs in essential oils. The compound has been identified in over 200 plant species and is present in emissions from many trees.

β-Myrcene serves as an important industrial precursor for synthesizing menthol, geraniol and other terpenes.